{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9(5)"],"submitter":["Yamaoka T"],"journal":["Translational lung cancer research"],"pagination":["2178-2183"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7653124"],"repository":["biostudies-literature"],"pubmed_title":["HER2-D16 oncogenic driver mutation confers osimertinib resistance in EGFR mutation-positive non-small cell lung cancer."],"pmcid":["PMC7653124"],"pubmed_authors":["Ohmori T","Tsurutani J","Sagara H","Yamaoka T"],"additional_accession":[]},"is_claimable":false,"name":"HER2-D16 oncogenic driver mutation confers osimertinib resistance in EGFR mutation-positive non-small cell lung cancer.","description":null,"dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Oct","modification":"2025-04-19T23:40:15.239Z","creation":"2025-04-19T23:40:15.239Z"},"accession":"S-EPMC7653124","cross_references":{"pubmed":["33209639"],"doi":["10.21037/tlcr-20-578"]}}